首页 > 最新文献

Lancet Microbe最新文献

英文 中文
Central African mpox spillovers: a harbinger of accelerating zoonotic threats 中非麻疹外溢:人畜共患威胁加速的先兆。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-09-23 DOI: 10.1016/j.lanmic.2025.101252
Yuxuan Song , Jie Liu , Meng Zhang , Jingyuan Ning
{"title":"Central African mpox spillovers: a harbinger of accelerating zoonotic threats","authors":"Yuxuan Song , Jie Liu , Meng Zhang , Jingyuan Ning","doi":"10.1016/j.lanmic.2025.101252","DOIUrl":"10.1016/j.lanmic.2025.101252","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101252"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145179467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trial 多成分培训干预(清洁前线)对柬埔寨转诊医院微生物清洁度的影响:一项多中心、楔形踏步、聚类随机试验
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-12-11 DOI: 10.1016/j.lanmic.2025.101262
Giorgia Gon PhD , Sokvy Ma MSc , Alexander M Aiken PhD , Prof Stephanie J Dancer PhD , Prof Wendy J Graham PhD , Stephen Nash MSc , Vandarith Nov MSc , Sovathiro Mao MSc , Bernice Sarpong MSc , Maxine Pepper MSc , Sreytouch Vong MSc , Vouchnea Tang BA , Jennifer Thompson PhD , Ir Por PhD

Background

Cleanliness of near-patient hospital surfaces is essential for preventing health care-associated infections and the spread of antimicrobial-resistant pathogens. Randomised evaluations of cleaning interventions have not been done in low-resource settings. We assessed the effectiveness of a hospital-based training intervention (Clean Frontline) to improve the microbiological cleanliness of near-patient surfaces.

Methods

In this stepped-wedge, cluster-randomised trial in 13 Cambodian referral hospitals, we defined four steps (timings) that define the transition from control to intervention. All eligible public referral hospitals (district or provincial) in three selected provinces consented to participate. Pre-intervention, environmental cleaning practices remained unchanged. The multicomponent intervention selected, trained, and supervised facility cleaning champions, who in turn trained and supervised hospital cleaners. The primary outcome was microbiological cleanliness of near-patient surfaces, assessed using dipslides (a surface with <2·5 colony-forming units per cm2 was classified as clean). 30 samples per hospital were collected monthly over 10 months. Outcome data collection and analysis teams were masked to treatment allocation. The primary outcome was estimated at surface level (primary analysis, odds ratio) and hospital level (risk difference), using an intention-to-treat approach and adjusted for a-priori confounders: temperature, patient numbers, beds per cleaner, and surface type. This trial is registered with ClinicalTrials.gov, NCT05540886, and is complete.

Findings

Across the 13 participating hospitals, a total of 53 champions and 51 cleaners were trained. Outcomes were measured monthly between May 3, 2022, and March 23, 2023. We collected 3900 samples, 3822 of which were used in the analyses. We observed a positive, although non-significant, effect of the intervention on cleanliness in the surface analysis (odds ratio 1·39 [95% CI 0·95–2·03], p=0·081). The hospital-level analysis indicated a significant improvement of 5·04 percentage points (95% CI 0·76–9·33, p=0·026).

Interpretation

Improving microbiological cleanliness of near-patient surfaces in hospitals in low-resource settings through the delivery of context-appropriate training and support is feasible. Further research should test this intervention with a wider number of clusters. Lessons learnt from the implementation will inform WHO roll-out of the training package.

Funding

Who Gives A Crap and the Reckitt Global Hygiene Institute.
背景:医院近病人表面的清洁对于预防卫生保健相关感染和耐药病原体的传播至关重要。在资源匮乏的环境中,尚未对清洁干预措施进行随机评估。我们评估了以医院为基础的培训干预(清洁前线)的有效性,以提高患者附近表面的微生物清洁度。方法:在13家柬埔寨转诊医院进行的这一楔形分步、聚类随机试验中,我们定义了四个步骤(时间)来定义从控制到干预的过渡。在选定的三个省,所有符合条件的公立转诊医院(区或省)都同意参与。干预前的环境清洁做法保持不变。多组分干预选择,培训和监督设施清洁冠军,他们反过来培训和监督医院清洁工。主要结果是用蘸片评估患者附近表面的微生物清洁度(2级表面为清洁)。每家医院在10个月内每月采集30份样本。结果数据收集和分析小组对治疗分配不知情。主要结局在表面水平(主要分析,优势比)和医院水平(风险差异)进行估计,使用意向治疗方法,并根据先验混杂因素进行调整:温度、患者数量、每个清洁工的床位和表面类型。该试验已在ClinicalTrials.gov注册,编号NCT05540886,并且已经完成。结果:在13家参与医院中,共有53名冠军和51名清洁工接受了培训。结果在2022年5月3日至2023年3月23日期间每月测量一次。我们收集了3900个样本,其中3822个用于分析。在表面分析中,我们观察到干预对清洁度的积极影响,尽管不显著(优势比1.39 [95% CI 0.95 - 2.03], p= 0.081)。医院水平分析显示,显著改善5.04个百分点(95% CI 0.76 - 9.33, p= 0.026)。解释:在资源匮乏的环境中,通过提供适合环境的培训和支持,改善医院近病人表面的微生物清洁度是可行的。进一步的研究应该在更广泛的群体中检验这种干预措施。从实施中吸取的经验教训将为世卫组织推出一揽子培训提供参考。资助:Who Gives A Crap和利洁时全球卫生研究所。
{"title":"Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trial","authors":"Giorgia Gon PhD ,&nbsp;Sokvy Ma MSc ,&nbsp;Alexander M Aiken PhD ,&nbsp;Prof Stephanie J Dancer PhD ,&nbsp;Prof Wendy J Graham PhD ,&nbsp;Stephen Nash MSc ,&nbsp;Vandarith Nov MSc ,&nbsp;Sovathiro Mao MSc ,&nbsp;Bernice Sarpong MSc ,&nbsp;Maxine Pepper MSc ,&nbsp;Sreytouch Vong MSc ,&nbsp;Vouchnea Tang BA ,&nbsp;Jennifer Thompson PhD ,&nbsp;Ir Por PhD","doi":"10.1016/j.lanmic.2025.101262","DOIUrl":"10.1016/j.lanmic.2025.101262","url":null,"abstract":"<div><h3>Background</h3><div>Cleanliness of near-patient hospital surfaces is essential for preventing health care-associated infections and the spread of antimicrobial-resistant pathogens. Randomised evaluations of cleaning interventions have not been done in low-resource settings. We assessed the effectiveness of a hospital-based training intervention (Clean Frontline) to improve the microbiological cleanliness of near-patient surfaces.</div></div><div><h3>Methods</h3><div>In this stepped-wedge, cluster-randomised trial in 13 Cambodian referral hospitals, we defined four steps (timings) that define the transition from control to intervention. All eligible public referral hospitals (district or provincial) in three selected provinces consented to participate. Pre-intervention, environmental cleaning practices remained unchanged. The multicomponent intervention selected, trained, and supervised facility cleaning champions, who in turn trained and supervised hospital cleaners. The primary outcome was microbiological cleanliness of near-patient surfaces, assessed using dipslides (a surface with &lt;2·5 colony-forming units per cm<sup>2</sup> was classified as clean). 30 samples per hospital were collected monthly over 10 months. Outcome data collection and analysis teams were masked to treatment allocation. The primary outcome was estimated at surface level (primary analysis, odds ratio) and hospital level (risk difference), using an intention-to-treat approach and adjusted for a-priori confounders: temperature, patient numbers, beds per cleaner, and surface type. This trial is registered with <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span>, <span><span>NCT05540886</span><svg><path></path></svg></span>, and is complete.</div></div><div><h3>Findings</h3><div>Across the 13 participating hospitals, a total of 53 champions and 51 cleaners were trained. Outcomes were measured monthly between May 3, 2022, and March 23, 2023. We collected 3900 samples, 3822 of which were used in the analyses. We observed a positive, although non-significant, effect of the intervention on cleanliness in the surface analysis (odds ratio 1·39 [95% CI 0·95–2·03], p=0·081). The hospital-level analysis indicated a significant improvement of 5·04 percentage points (95% CI 0·76–9·33, p=0·026).</div></div><div><h3>Interpretation</h3><div>Improving microbiological cleanliness of near-patient surfaces in hospitals in low-resource settings through the delivery of context-appropriate training and support is feasible. Further research should test this intervention with a wider number of clusters. Lessons learnt from the implementation will inform WHO roll-out of the training package.</div></div><div><h3>Funding</h3><div>Who Gives A Crap and the Reckitt Global Hygiene Institute.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101262"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale 需要从结核病研究中建立相互关联的全球生物库,以大规模解决基本问题。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-12-22 DOI: 10.1016/j.lanmic.2025.101279
Cara Adolph PhD , Simon C Mendelsohn PhD , Laura E Via PhD , Leonardo Martinez PhD , Cecilia S Lindestam Arlehamn PhD , Prof David M Lewinsohn PhD , Jordi B Torrelles PhD , Prof Philip C Hill MD
Tuberculosis remains a leading cause of death, underscoring the urgent need for a new vaccine. Progress in vaccine development is hampered by incomplete understanding of how Mycobacterium tuberculosis causes infection and disease, and of protective immunity following natural infection and vaccination. Addressing these gaps requires biological samples from tuberculosis cases and contacts or healthy controls as well as from protected and unprotected vaccinated individuals. Numerous observational studies and clinical trials on tuberculosis are conducted each year, collecting and storing diverse samples—including blood derivatives, urine, sputum, saliva, and even radiographic images—from participants. In this Personal View, we suggest that pooling samples from these studies could enable the scientific community to address important and understudied research questions at an unprecedented scale. This approach could generate new insights into fundamental disease mechanisms and the requirements for an effective vaccine. We propose linking existing biorepositories from tuberculosis studies worldwide to facilitate large-scale studies and accelerate breakthroughs in tuberculosis vaccine development.
结核病仍然是导致死亡的主要原因,因此迫切需要一种新疫苗。由于对结核分枝杆菌如何引起感染和疾病以及对自然感染和疫苗接种后的保护性免疫的不完全了解,阻碍了疫苗开发的进展。要解决这些差距,需要从结核病病例和接触者或健康对照者以及受保护和未受保护的接种疫苗者身上采集生物样本。每年对结核病进行大量观察性研究和临床试验,收集和储存来自参与者的各种样本,包括血液衍生物、尿液、痰液、唾液,甚至放射影像。在这个个人观点中,我们建议从这些研究中收集样本可以使科学界以前所未有的规模解决重要的和未被充分研究的研究问题。这种方法可以对基本疾病机制和有效疫苗的需求产生新的见解。我们建议将全球结核病研究的现有生物储存库联系起来,以促进大规模研究并加速结核病疫苗开发的突破。
{"title":"The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale","authors":"Cara Adolph PhD ,&nbsp;Simon C Mendelsohn PhD ,&nbsp;Laura E Via PhD ,&nbsp;Leonardo Martinez PhD ,&nbsp;Cecilia S Lindestam Arlehamn PhD ,&nbsp;Prof David M Lewinsohn PhD ,&nbsp;Jordi B Torrelles PhD ,&nbsp;Prof Philip C Hill MD","doi":"10.1016/j.lanmic.2025.101279","DOIUrl":"10.1016/j.lanmic.2025.101279","url":null,"abstract":"<div><div>Tuberculosis remains a leading cause of death, underscoring the urgent need for a new vaccine. Progress in vaccine development is hampered by incomplete understanding of how <em>Mycobacterium tuberculosis</em> causes infection and disease, and of protective immunity following natural infection and vaccination. Addressing these gaps requires biological samples from tuberculosis cases and contacts or healthy controls as well as from protected and unprotected vaccinated individuals. Numerous observational studies and clinical trials on tuberculosis are conducted each year, collecting and storing diverse samples—including blood derivatives, urine, sputum, saliva, and even radiographic images—from participants. In this Personal View, we suggest that pooling samples from these studies could enable the scientific community to address important and understudied research questions at an unprecedented scale. This approach could generate new insights into fundamental disease mechanisms and the requirements for an effective vaccine. We propose linking existing biorepositories from tuberculosis studies worldwide to facilitate large-scale studies and accelerate breakthroughs in tuberculosis vaccine development.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101279"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From vaccination success to new outbreaks: reassessing Japanese encephalitis control in Nepal 从疫苗接种成功到新的疫情:重新评估尼泊尔的日本脑炎控制。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-10-09 DOI: 10.1016/j.lanmic.2025.101260
Krishna Prasad Acharya , Francesco Branda , Sarita Phuyal , Massimo Ciccozzi , Fabio Scarpa , Hemraj Kandu , Richard Trevor Wilson , Kishor Pandey , Sher Bahadur Pun
{"title":"From vaccination success to new outbreaks: reassessing Japanese encephalitis control in Nepal","authors":"Krishna Prasad Acharya ,&nbsp;Francesco Branda ,&nbsp;Sarita Phuyal ,&nbsp;Massimo Ciccozzi ,&nbsp;Fabio Scarpa ,&nbsp;Hemraj Kandu ,&nbsp;Richard Trevor Wilson ,&nbsp;Kishor Pandey ,&nbsp;Sher Bahadur Pun","doi":"10.1016/j.lanmic.2025.101260","DOIUrl":"10.1016/j.lanmic.2025.101260","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101260"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation and outcomes of a rapid response genomic hospital epidemiology programme at an academic medical centre over 7 years 一个学术医疗中心7年来快速反应基因组医院流行病学方案的执行情况和结果。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2026-01-06 DOI: 10.1016/j.lanmic.2025.101277
Victoria T Chu MD MPH , Natasha Spottiswoode MD DPhil , Ryan Ward BS , Deborah S Yokoe MD , Lynn Ramirez-Avila MD , Maira S Phelps BS , Abigail Glascock PhD , Emily D Crawford PhD , Jack Kamm PhD , Samantha Hao MD , Lucy Li PhD , David Dynerman PhD , Eric Waltari PhD , Saba Nafees PhD , Katrina L Kalantar PhD , Saharai Caldera BS , Sharline Madera MD , Estella Sanchez Guerrero PhD , Daniel Ivashin BS , Paula Hayakawa Serpa MD , Charles R Langelier MD PhD
Advances in genomic technologies have revolutionised practices for hospital infection prevention and control programmes. In this Personal View, we describe a genomic epidemiology service called the Rapid Response (RR) programme at University of California, San Francisco, a large academic medical centre. In collaboration with the hospital infection-prevention team, the RR programme uses whole-genome sequencing and metagenomic next-generation sequencing for outbreak investigations, special interest analyses of emerging pathogens, and surveillance of high-priority microbes. Over 7 years (2017–24), the RR programme conducted a diversity of outbreak investigations and other analyses; most investigations ruled out transmission, and the rapid turnaround of genomic results averted further resource-intensive work. Longitudinal surveillance enabled early detection of changing incidence trends and guided timely infection-prevention responses. Our experiences with the RR programme build upon growing evidence that genomic epidemiology programmes enhance hospital infection prevention and control, augment priority pathogen surveillance, and improve patient safety.
基因组技术的进步彻底改变了医院感染预防和控制规划的做法。在本个人观点中,我们描述了加州大学旧金山分校(一个大型学术医疗中心)一个名为快速反应(RR)项目的基因组流行病学服务。预防感染方案与医院感染预防小组合作,利用全基因组测序和新一代宏基因组测序进行疫情调查、对新发病原体的特殊兴趣分析以及对重点微生物的监测。在7年(2017-24年)期间,预防感染规划开展了多种疫情调查和其他分析;大多数调查排除了传播的可能性,基因组结果的快速转变避免了进一步的资源密集型工作。纵向监测能够早期发现不断变化的发病率趋势,并指导及时的感染预防反应。越来越多的证据表明,基因组流行病学规划加强了医院感染预防和控制,加强了重点病原体监测,并改善了患者安全。
{"title":"Implementation and outcomes of a rapid response genomic hospital epidemiology programme at an academic medical centre over 7 years","authors":"Victoria T Chu MD MPH ,&nbsp;Natasha Spottiswoode MD DPhil ,&nbsp;Ryan Ward BS ,&nbsp;Deborah S Yokoe MD ,&nbsp;Lynn Ramirez-Avila MD ,&nbsp;Maira S Phelps BS ,&nbsp;Abigail Glascock PhD ,&nbsp;Emily D Crawford PhD ,&nbsp;Jack Kamm PhD ,&nbsp;Samantha Hao MD ,&nbsp;Lucy Li PhD ,&nbsp;David Dynerman PhD ,&nbsp;Eric Waltari PhD ,&nbsp;Saba Nafees PhD ,&nbsp;Katrina L Kalantar PhD ,&nbsp;Saharai Caldera BS ,&nbsp;Sharline Madera MD ,&nbsp;Estella Sanchez Guerrero PhD ,&nbsp;Daniel Ivashin BS ,&nbsp;Paula Hayakawa Serpa MD ,&nbsp;Charles R Langelier MD PhD","doi":"10.1016/j.lanmic.2025.101277","DOIUrl":"10.1016/j.lanmic.2025.101277","url":null,"abstract":"<div><div>Advances in genomic technologies have revolutionised practices for hospital infection prevention and control programmes. In this Personal View, we describe a genomic epidemiology service called the Rapid Response (RR) programme at University of California, San Francisco, a large academic medical centre. In collaboration with the hospital infection-prevention team, the RR programme uses whole-genome sequencing and metagenomic next-generation sequencing for outbreak investigations, special interest analyses of emerging pathogens, and surveillance of high-priority microbes. Over 7 years (2017–24), the RR programme conducted a diversity of outbreak investigations and other analyses; most investigations ruled out transmission, and the rapid turnaround of genomic results averted further resource-intensive work. Longitudinal surveillance enabled early detection of changing incidence trends and guided timely infection-prevention responses. Our experiences with the RR programme build upon growing evidence that genomic epidemiology programmes enhance hospital infection prevention and control, augment priority pathogen surveillance, and improve patient safety.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101277"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145946565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune maturity, not seropositivity, determines protection from congenital CMV 免疫成熟,而不是血清阳性,决定对先天性巨细胞病毒的保护。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-09-23 DOI: 10.1016/j.lanmic.2025.101249
Eleni Georgakopoulou , Nitya Krishnasamy , Hema Shree K , Sameep Shetty
{"title":"Immune maturity, not seropositivity, determines protection from congenital CMV","authors":"Eleni Georgakopoulou ,&nbsp;Nitya Krishnasamy ,&nbsp;Hema Shree K ,&nbsp;Sameep Shetty","doi":"10.1016/j.lanmic.2025.101249","DOIUrl":"10.1016/j.lanmic.2025.101249","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101249"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145179458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study 2018年至2023年间新出现的耐特比萘芬吲哚毛癣菌:一项多国基因组流行病学研究。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1016/j.lanmic.2025.101273
Johanna Rhodes PhD , Sui Ting Hui MRes , Sarah Dellière MD , Richard C Summerbell PhD , James A Scott PhD , Amtoj Kaur MSc , Richard C Barton PhD , Rodrigo Leitao MSc , Samuel Hemmings MSc , Rebeca Goiriz MD , Jonathan Lambourne PhD , Rhys A Farrer PhD , Silke Schelenz PhD , Prof Roderick J Hay DM , Prof Andrew M Borman PhD , Prof Anuradha Chowdhary MD , Alireza Abdolrasouli PhD , Prof Matthew C Fisher PhD

Background

Trichophyton species cause the greatest burden of dermatophytosis worldwide, with the Trichophyton mentagrophytes species complex being particularly associated with the emergence of new aggressive infections. One emerging species, Trichophyton indotineae is notable for its clinical resistance to terbinafine antifungal treatment and rapid global spread. In this study we aim to characterise the epidemiology of this emerging pathogen using genomics.

Methods

In this retrospective genomic epidemiology study, to better understand the epidemiology of this disease, we sourced isolates collected from patients with severe cases of dermatophytosis (identified either by internal transcribed spacer sequencing or phenotypic characterisation) in the UK, Ireland, France, Canada, and India for the period 2014–23, including the T indotineae type strain from Japan. We used whole-genome sequencing to confirm 90 isolates were T indotineae, and antifungal susceptibility testing to assess susceptibility to terbinafine.

Findings

103 cases of severe dermatophytosis caused by Trichophyton species collected between 2018 and 2023 in the UK, France, Canada, Ireland, and India were included in this study. Susceptibility testing indicated that 63 (70%) of 90 T indotineae isolates were resistant to terbinafine (minimum inhibitory concentration [MIC] ≥0·5 mg/L). Pairwise genetic distances showed very high identity with only 147 (range 1–414) single-nucleotide polymorphisms (SNPs) separating isolates that were nested within a monophyletic phylogeny, supporting a single evolutionary origin of T indotineae. Genome-wide analyses identified multiple non-synonymous SNPs in SQLE (ERG1), the squalene epoxidase target of terbinafine, that were associated with terbinafine in vitro resistance of 0·5 mg/L or higher. However, six isolates exhibited high MIC values without SQLE mutations, suggesting the presence of alternative resistance mechanisms.

Interpretation

That no clear geographical clustering of isolates was observed confirms the rapid transcontinental spread of T indotineae from its likely centre of diversity in Asia. Our findings highlight the importance of better genomic surveillance to understand and manage this severe and rapidly emerging terbinafine-resistant dermatophyte.

Funding

None.
背景:在世界范围内,毛癣菌是造成皮肤真菌病最大负担的物种,特别是与新的侵袭性感染的出现有关。作为一种新兴物种,印朵毛癣菌因其对特比萘芬抗真菌治疗的临床耐药性和迅速的全球传播而闻名。在这项研究中,我们的目标是利用基因组学来描述这种新兴病原体的流行病学。方法:在这项回顾性基因组流行病学研究中,为了更好地了解这种疾病的流行病学,我们收集了2014-23年期间英国、爱尔兰、法国、加拿大和印度的严重皮肤癣患者(通过内部转录间隔序列或表型特征鉴定)的分离株,包括来自日本的T indotineae型菌株。我们通过全基因组测序确认90株分离株为T indottineae,并通过抗真菌药敏试验评估对特比萘芬的敏感性。研究结果:本研究纳入了2018年至2023年间在英国、法国、加拿大、爱尔兰和印度收集的103例由毛癣菌引起的严重皮肤真菌病。药敏试验结果显示,90株T indotineae菌株中63株(70%)对特比萘芬耐药(最小抑制浓度[MIC]≥0.5 mg/L)。对遗传距离显示出非常高的一致性,在单系系统发育中只有147个(范围1-414个)单核苷酸多态性(snp),支持T indodinae的单一进化起源。全基因组分析发现,在特比萘芬的角鲨烯环氧化酶靶点SQLE (ERG1)中存在多个非同义snp,这些snp与特比萘芬0.5 mg/L或更高的体外耐药性有关。然而,6株分离株在没有SQLE突变的情况下表现出较高的MIC值,表明存在其他耐药机制。解释:未观察到明显的地理聚类,这证实了T indotineae从其可能的多样性中心亚洲迅速跨大陆传播。我们的研究结果强调了更好的基因组监测的重要性,以了解和管理这种严重的和迅速出现的特比萘芬耐药皮肤真菌。资金:没有。
{"title":"Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study","authors":"Johanna Rhodes PhD ,&nbsp;Sui Ting Hui MRes ,&nbsp;Sarah Dellière MD ,&nbsp;Richard C Summerbell PhD ,&nbsp;James A Scott PhD ,&nbsp;Amtoj Kaur MSc ,&nbsp;Richard C Barton PhD ,&nbsp;Rodrigo Leitao MSc ,&nbsp;Samuel Hemmings MSc ,&nbsp;Rebeca Goiriz MD ,&nbsp;Jonathan Lambourne PhD ,&nbsp;Rhys A Farrer PhD ,&nbsp;Silke Schelenz PhD ,&nbsp;Prof Roderick J Hay DM ,&nbsp;Prof Andrew M Borman PhD ,&nbsp;Prof Anuradha Chowdhary MD ,&nbsp;Alireza Abdolrasouli PhD ,&nbsp;Prof Matthew C Fisher PhD","doi":"10.1016/j.lanmic.2025.101273","DOIUrl":"10.1016/j.lanmic.2025.101273","url":null,"abstract":"<div><h3>Background</h3><div><em>Trichophyton</em> species cause the greatest burden of dermatophytosis worldwide, with the <em>Trichophyton mentagrophytes</em> species complex being particularly associated with the emergence of new aggressive infections. One emerging species, <em>Trichophyton indotineae</em> is notable for its clinical resistance to terbinafine antifungal treatment and rapid global spread. In this study we aim to characterise the epidemiology of this emerging pathogen using genomics.</div></div><div><h3>Methods</h3><div>In this retrospective genomic epidemiology study, to better understand the epidemiology of this disease, we sourced isolates collected from patients with severe cases of dermatophytosis (identified either by internal transcribed spacer sequencing or phenotypic characterisation) in the UK, Ireland, France, Canada, and India for the period 2014–23, including the <em>T indotineae</em> type strain from Japan. We used whole-genome sequencing to confirm 90 isolates were <em>T indotineae</em>, and antifungal susceptibility testing to assess susceptibility to terbinafine.</div></div><div><h3>Findings</h3><div>103 cases of severe dermatophytosis caused by <em>Trichophyton</em> species collected between 2018 and 2023 in the UK, France, Canada, Ireland, and India were included in this study. Susceptibility testing indicated that 63 (70%) of 90 <em>T indotineae</em> isolates were resistant to terbinafine (minimum inhibitory concentration [MIC] ≥0·5 mg/L). Pairwise genetic distances showed very high identity with only 147 (range 1–414) single-nucleotide polymorphisms (SNPs) separating isolates that were nested within a monophyletic phylogeny, supporting a single evolutionary origin of <em>T indotineae</em>. Genome-wide analyses identified multiple non-synonymous SNPs in <em>SQLE</em> (<em>ERG1</em>), the squalene epoxidase target of terbinafine, that were associated with terbinafine in vitro resistance of 0·5 mg/L or higher. However, six isolates exhibited high MIC values without <em>SQLE</em> mutations, suggesting the presence of alternative resistance mechanisms.</div></div><div><h3>Interpretation</h3><div>That no clear geographical clustering of isolates was observed confirms the rapid transcontinental spread of <em>T indotineae</em> from its likely centre of diversity in Asia. Our findings highlight the importance of better genomic surveillance to understand and manage this severe and rapidly emerging terbinafine-resistant dermatophyte.</div></div><div><h3>Funding</h3><div>None.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"7 2","pages":"Article 101273"},"PeriodicalIF":20.4,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review. 通过临床数据解释尼帕病毒病的自然历史和发病机制,为临床试验设计提供信息:一项系统评价。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-24 DOI: 10.1016/j.lanmic.2025.101295
Md Zakiul Hassan, Susan Khader Ibrahim, Eli Harriss, Peter Horby, Piero Olliaro, Amanda Rojek

Nipah virus is a priority pathogen with high mortality and pandemic potential. Therapies for Nipah virus disease, such as monoclonal antibodies and antivirals, are under development and require clinical trials for evaluation. However, designing such trials is challenging due to the limited understanding of the clinical characteristics, pathogenesis, and current management of Nipah virus disease. In this Review, we gathered essential data from 59 studies reporting 717 Nipah virus disease cases, to inform trial design. Nearly all patients (618 [99%] of 624) had fever. Neurological symptoms included headache (419 [70%] of 601 patients), confusion (74 [65%] of 114), and altered consciousness (358 [62%] of 580); respiratory symptoms included cough (244 [45%] of 541) and difficulty in breathing (184 [58%] of 317). Imaging data revealed chest abnormalities (29 [80%] of 36) and brain involvement (40 [71%] of 56). Viral RNA was detectable early in illness across various sample types. The median case-fatality rate was 69% (IQR 31-88%), with 51 (26%) of 197 survivors presenting with persistent neurological deficits. Clinical management varied widely, with incomplete reporting limiting insights. Prospective observational studies are needed to generate actionable data on clinical case definitions, predictors of adverse outcomes, current standards of care, and standardised endpoints, to inform future trials.

尼帕病毒是具有高死亡率和大流行潜力的优先病原体。尼帕病毒病的治疗方法,如单克隆抗体和抗病毒药物,正在开发中,需要进行临床试验以进行评估。然而,由于对尼帕病毒病的临床特征、发病机制和目前管理的了解有限,设计这样的试验具有挑战性。在本综述中,我们收集了报告717例尼帕病毒病病例的59项研究的基本数据,为试验设计提供信息。几乎所有患者(624例中618例[99%])均有发热。神经系统症状包括头痛(601例患者中419例[70%])、意识模糊(114例患者中74例[65%])和意识改变(580例患者中358例[62%]);呼吸道症状包括咳嗽(541例中有244例(45%))和呼吸困难(317例中有184例(58%))。影像学资料显示胸部异常(36例中29例[80%])和脑部受累(56例中40例[71%])。病毒RNA在各种样本类型的疾病早期都可以检测到。中位病死率为69% (IQR 31-88%), 197名幸存者中有51人(26%)出现持续的神经功能缺损。临床管理差异很大,不完整的报告限制了见解。需要前瞻性观察性研究来产生关于临床病例定义、不良后果预测因素、当前护理标准和标准化终点的可操作数据,以便为未来的试验提供信息。
{"title":"Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review.","authors":"Md Zakiul Hassan, Susan Khader Ibrahim, Eli Harriss, Peter Horby, Piero Olliaro, Amanda Rojek","doi":"10.1016/j.lanmic.2025.101295","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101295","url":null,"abstract":"<p><p>Nipah virus is a priority pathogen with high mortality and pandemic potential. Therapies for Nipah virus disease, such as monoclonal antibodies and antivirals, are under development and require clinical trials for evaluation. However, designing such trials is challenging due to the limited understanding of the clinical characteristics, pathogenesis, and current management of Nipah virus disease. In this Review, we gathered essential data from 59 studies reporting 717 Nipah virus disease cases, to inform trial design. Nearly all patients (618 [99%] of 624) had fever. Neurological symptoms included headache (419 [70%] of 601 patients), confusion (74 [65%] of 114), and altered consciousness (358 [62%] of 580); respiratory symptoms included cough (244 [45%] of 541) and difficulty in breathing (184 [58%] of 317). Imaging data revealed chest abnormalities (29 [80%] of 36) and brain involvement (40 [71%] of 56). Viral RNA was detectable early in illness across various sample types. The median case-fatality rate was 69% (IQR 31-88%), with 51 (26%) of 197 survivors presenting with persistent neurological deficits. Clinical management varied widely, with incomplete reporting limiting insights. Prospective observational studies are needed to generate actionable data on clinical case definitions, predictors of adverse outcomes, current standards of care, and standardised endpoints, to inform future trials.</p>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101295"},"PeriodicalIF":20.4,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146067646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversing resistance? Declines in macrolide-resistant STIs following antimicrobial stewardship interventions in Belgium. 逆转耐药性?比利时抗菌素管理干预后大环内酯耐药性传播感染的下降。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-19 DOI: 10.1016/j.lanmic.2025.101297
Thibaut Vanbaelen, Irith De Baetselier, Achilleas Tsoumanis, Bernadette Hensen, Dorien Van den Bossche, Chris Kenyon
{"title":"Reversing resistance? Declines in macrolide-resistant STIs following antimicrobial stewardship interventions in Belgium.","authors":"Thibaut Vanbaelen, Irith De Baetselier, Achilleas Tsoumanis, Bernadette Hensen, Dorien Van den Bossche, Chris Kenyon","doi":"10.1016/j.lanmic.2025.101297","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101297","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101297"},"PeriodicalIF":20.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low paediatric vaccination rates in Argentina. 阿根廷儿童疫苗接种率低。
IF 20.4 1区 生物学 Q1 INFECTIOUS DISEASES Pub Date : 2026-01-17 DOI: 10.1016/j.lanmic.2026.101346
Sanjeet Bagcchi
{"title":"Low paediatric vaccination rates in Argentina.","authors":"Sanjeet Bagcchi","doi":"10.1016/j.lanmic.2026.101346","DOIUrl":"https://doi.org/10.1016/j.lanmic.2026.101346","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101346"},"PeriodicalIF":20.4,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146012834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Microbe
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1